DTaP and Tdap Vaccines Market Report

Europe DTaP and Tdap Vaccines Market Size, Status and Forecast 2014-2026

  • POSTDATE：Dec 17, 2019
  • PAGES：153
  • REPORT CODE：GMM401309
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The DTaP and Tdap Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.6% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe DTaP and Tdap Vaccines Market Segmentations:

    By Player:

    • Merck Sharp & Dohme Corp

    • Lanzhou Institute of Biological Products Co., Ltd

    • Johnson & Johnson

    • Emergent BioSolutions Inc

    • Protein Sciences Corporation

    • Novartis AG

    • Lanzhou Institute of Biological Products Co, Ltd

    • Pfizer Inc

    • GlaxoSmithKline

    • Astellas Pharma US, Inc

    • AstraZeneca

    • Sanofi Pasteur

    By Type:

    • DTaP

    • Td

    • Tdap

    By End-User:

    • Tdap

    • Tdap

    • Tdap

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of DTaP and Tdap Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe DTaP and Tdap Vaccines Market Size and Growth Rate of DTaP from 2014 to 2026

    • 1.3.2 Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Td from 2014 to 2026

    • 1.3.3 Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Tdap from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Tdap from 2014 to 2026

    • 1.4.2 Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Tdap from 2014 to 2026

    • 1.4.3 Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Tdap from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of DTaP and Tdap Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of DTaP and Tdap Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of DTaP

      • 3.4.2 Market Size and Growth Rate of Td

      • 3.4.3 Market Size and Growth Rate of Tdap

    4 Segmentation of DTaP and Tdap Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of DTaP and Tdap Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of DTaP and Tdap Vaccines for Tdap

      • 4.4.2 Market Size and Growth Rate of DTaP and Tdap Vaccines for Tdap

      • 4.4.3 Market Size and Growth Rate of DTaP and Tdap Vaccines for Tdap

    5 Market Analysis by Major Regions

    • 5.1 Europe DTaP and Tdap Vaccines Production Analysis by Top Regions

    • 5.2 Europe DTaP and Tdap Vaccines Consumption Analysis by Top Regions

    • 5.3 Europe DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 France DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of DTaP and Tdap Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in DTaP and Tdap Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in DTaP and Tdap Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in DTaP and Tdap Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in DTaP and Tdap Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in DTaP and Tdap Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in DTaP and Tdap Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany DTaP and Tdap Vaccines Landscape Analysis

    • 7.1 Germany DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 7.2 Germany DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    8. UK DTaP and Tdap Vaccines Landscape Analysis

    • 8.1 UK DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 8.2 UK DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    9. France DTaP and Tdap Vaccines Landscape Analysis

    • 9.1 France DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 9.2 France DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    10. Italy DTaP and Tdap Vaccines Landscape Analysis

    • 10.1 Italy DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 10.2 Italy DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    11. Spain DTaP and Tdap Vaccines Landscape Analysis

    • 11.1 Spain DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 11.2 Spain DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    12. Poland DTaP and Tdap Vaccines Landscape Analysis

    • 12.1 Poland DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 12.2 Poland DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    13. Russia DTaP and Tdap Vaccines Landscape Analysis

    • 13.1 Russia DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 13.2 Russia DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    14. Switzerland DTaP and Tdap Vaccines Landscape Analysis

    • 14.1 Switzerland DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 14.2 Switzerland DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    15. Turkey DTaP and Tdap Vaccines Landscape Analysis

    • 15.1 Turkey DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 15.2 Turkey DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Landscape Analysis by Top Countries

      • 16.3.1 Denmark DTaP and Tdap Vaccines Market Volume and Growth Rate

      • 16.3.2 Finland DTaP and Tdap Vaccines Market Volume and Growth Rate

      • 16.3.3 Norway DTaP and Tdap Vaccines Market Volume and Growth Rate

      • 16.3.4 Sweden DTaP and Tdap Vaccines Market Volume and Growth Rate

      • 16.3.6 Iceland DTaP and Tdap Vaccines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Landscape Analysis by Top Countries

      • 17.3.1 Belgium DTaP and Tdap Vaccines Market Volume and Growth Rate

      • 17.3.2 Netherlands DTaP and Tdap Vaccines Market Volume and Growth Rate

      • 17.3.3 Luxembourg DTaP and Tdap Vaccines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Landscape Analysis by Top Countries

      • 18.3.1 Estonia DTaP and Tdap Vaccines Market Volume and Growth Rate

      • 18.3.2 Latvia DTaP and Tdap Vaccines Market Volume and Growth Rate

      • 18.3.3 Lithuania DTaP and Tdap Vaccines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Merck Sharp & Dohme Corp

      • 19.1.1 Merck Sharp & Dohme Corp Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Lanzhou Institute of Biological Products Co., Ltd

      • 19.2.1 Lanzhou Institute of Biological Products Co., Ltd Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Johnson & Johnson

      • 19.3.1 Johnson & Johnson Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Emergent BioSolutions Inc

      • 19.4.1 Emergent BioSolutions Inc Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Protein Sciences Corporation

      • 19.5.1 Protein Sciences Corporation Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Novartis AG

      • 19.6.1 Novartis AG Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Lanzhou Institute of Biological Products Co, Ltd

      • 19.7.1 Lanzhou Institute of Biological Products Co, Ltd Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Pfizer Inc

      • 19.8.1 Pfizer Inc Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 GlaxoSmithKline

      • 19.9.1 GlaxoSmithKline Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Astellas Pharma US, Inc

      • 19.10.1 Astellas Pharma US, Inc Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 AstraZeneca

      • 19.11.1 AstraZeneca Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Sanofi Pasteur

      • 19.12.1 Sanofi Pasteur Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    The List of Tables and Figures (Totals 66 Figures and 138 Tables)

    • Figure Product Picture

    • Figure Europe DTaP and Tdap Vaccines Market Size and Growth Rate of DTaP from 2014 to 2026

    • Figure Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Td from 2014 to 2026

    • Figure Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Tdap from 2014 to 2026

    • Figure Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Tdap from 2014 to 2026

    • Figure Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Tdap from 2014 to 2026

    • Figure Europe DTaP and Tdap Vaccines Market Size and Growth Rate of Tdap from 2014 to 2026

    • Figure Germany DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania DTaP and Tdap Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of DTaP and Tdap Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of DTaP and Tdap Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of DTaP and Tdap Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of DTaP and Tdap Vaccines by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of DTaP

    • Figure Market Size and Growth Rate of Td

    • Figure Market Size and Growth Rate of Tdap

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of DTaP and Tdap Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of DTaP and Tdap Vaccines by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Tdap

    • Figure Market Size and Growth Rate of Tdap

    • Figure Market Size and Growth Rate of Tdap

    • Table Europe DTaP and Tdap Vaccines Production by Major Regions

    • Table Europe DTaP and Tdap Vaccines Production Share by Major Regions

    • Figure Europe DTaP and Tdap Vaccines Production Share by Major Countries and Regions in 2014

    • Table Europe DTaP and Tdap Vaccines Consumption by Major Regions

    • Table Europe DTaP and Tdap Vaccines Consumption Share by Major Regions

    • Table Germany DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table UK DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table France DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Italy DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Spain DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Poland DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Russia DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Switzerland DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Turkey DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in DTaP and Tdap Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in DTaP and Tdap Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in DTaP and Tdap Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in DTaP and Tdap Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Germany DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Germany DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Germany DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table UK DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table UK DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table UK DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table UK DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table France DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table France DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table France DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table France DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Italy DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Italy DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Italy DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Italy DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Spain DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Spain DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Spain DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Spain DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Poland DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Poland DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Poland DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Poland DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Russia DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Russia DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Russia DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Russia DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Switzerland DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Switzerland DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Switzerland DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Turkey DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Turkey DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Turkey DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) DTaP and Tdap Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) DTaP and Tdap Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) DTaP and Tdap Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries DTaP and Tdap Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Merck Sharp & Dohme Corp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Sharp & Dohme Corp

    • Figure Sales and Growth Rate Analysis of Merck Sharp & Dohme Corp

    • Figure Revenue and Market Share Analysis of Merck Sharp & Dohme Corp

    • Table Product and Service Introduction of Merck Sharp & Dohme Corp

    • Table Company Profile and Development Status of Lanzhou Institute of Biological Products Co., Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lanzhou Institute of Biological Products Co., Ltd

    • Figure Sales and Growth Rate Analysis of Lanzhou Institute of Biological Products Co., Ltd

    • Figure Revenue and Market Share Analysis of Lanzhou Institute of Biological Products Co., Ltd

    • Table Product and Service Introduction of Lanzhou Institute of Biological Products Co., Ltd

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Emergent BioSolutions Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emergent BioSolutions Inc

    • Figure Sales and Growth Rate Analysis of Emergent BioSolutions Inc

    • Figure Revenue and Market Share Analysis of Emergent BioSolutions Inc

    • Table Product and Service Introduction of Emergent BioSolutions Inc

    • Table Company Profile and Development Status of Protein Sciences Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Protein Sciences Corporation

    • Figure Sales and Growth Rate Analysis of Protein Sciences Corporation

    • Figure Revenue and Market Share Analysis of Protein Sciences Corporation

    • Table Product and Service Introduction of Protein Sciences Corporation

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Lanzhou Institute of Biological Products Co, Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lanzhou Institute of Biological Products Co, Ltd

    • Figure Sales and Growth Rate Analysis of Lanzhou Institute of Biological Products Co, Ltd

    • Figure Revenue and Market Share Analysis of Lanzhou Institute of Biological Products Co, Ltd

    • Table Product and Service Introduction of Lanzhou Institute of Biological Products Co, Ltd

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Astellas Pharma US, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma US, Inc

    • Figure Sales and Growth Rate Analysis of Astellas Pharma US, Inc

    • Figure Revenue and Market Share Analysis of Astellas Pharma US, Inc

    • Table Product and Service Introduction of Astellas Pharma US, Inc

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Sanofi Pasteur

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi Pasteur

    • Figure Sales and Growth Rate Analysis of Sanofi Pasteur

    • Figure Revenue and Market Share Analysis of Sanofi Pasteur

    • Table Product and Service Introduction of Sanofi Pasteur

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US